Solid Biosciences (SLDB) News Today $4.23 -0.08 (-1.76%) As of 01:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Rating of "Buy" by BrokeragesSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) has been assigned an average recommendation of "Buy" from the twelve brokerages that are covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and four have given a strong buy recoMay 4 at 2:43 AM | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Recommendation of "Buy" by BrokeragesMay 2 at 2:45 AM | americanbankingnews.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 1, 2025 | globenewswire.comSolid Biosciences to Present Phase 1/2 Trial Data for SGT-003 Gene Therapy at ASGCT 2025 Annual MeetingMay 1, 2025 | nasdaq.comSolid Biosciences to Participate at The Citizens Life Sciences ConferenceApril 30, 2025 | globenewswire.comSolid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual MeetingApril 29, 2025 | finance.yahoo.comSolid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual MeetingApril 29, 2025 | globenewswire.comResearch Analysts Set Expectations for SLDB Q1 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Solid Biosciences in a research report issued to clients and investors on Monday, April 21st. Leerink Partnrs analyst J. Schwartz expects that the company will poApril 26, 2025 | marketbeat.comBrokers Issue Forecasts for SLDB Q1 EarningsApril 26, 2025 | americanbankingnews.comWalleye Capital LLC Sells 233,270 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Walleye Capital LLC reduced its holdings in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 59.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 158,831 shares of the company's stock after selling 233,270 shares during the period. Walleye CapApril 25, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 945,863 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)JPMorgan Chase & Co. raised its position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 9,393.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 955,932 shares of the company's stock after puApril 22, 2025 | marketbeat.comTrexquant Investment LP Purchases 139,851 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Trexquant Investment LP lifted its position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 256.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 194,281 shares of the company's stock after purchasingApril 14, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Shares Sold by ADAR1 Capital Management LLCADAR1 Capital Management LLC cut its position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 87.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,903 shares of the company's stock afteApril 9, 2025 | marketbeat.comSolid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy SpaceApril 8, 2025 | seekingalpha.comCan Solid Biosciences Challenge Sarepta in the DMD Market?Solid Biosciences' Duchenne muscular dystrophy (DMD) drug could provide superior outcomes compared to an already approved medication projected to make billions.April 8, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Average Rating of "Buy" from AnalystsSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) has earned an average recommendation of "Buy" from the twelve ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and four have assigneApril 8, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Trading Down 7.9% - Time to Sell?Solid Biosciences (NASDAQ:SLDB) Stock Price Down 7.9% - Time to Sell?April 6, 2025 | marketbeat.comSolid Biosciences reports inducement grants under Nasdaq listing ruleApril 2, 2025 | markets.businessinsider.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 1, 2025 | globenewswire.comTruist Financial Keeps Their Buy Rating on Solid Biosciences (SLDB)March 21, 2025 | markets.businessinsider.comSolid Biosciences Inc. (SLDB): Among Top Insider Purchases Last MonthMarch 14, 2025 | insidermonkey.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Solid Biosciences (NASDAQ:SLDB) Stock PriceJPMorgan Chase & Co. lowered their price objective on Solid Biosciences from $12.00 to $11.00 and set an "overweight" rating for the company in a research report on Thursday.March 14, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Stock Price Up 0.5% - Still a Buy?Solid Biosciences (NASDAQ:SLDB) Trading Up 0.5% - What's Next?March 13, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of "Buy" from BrokeragesShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been given an average rating of "Buy" by the thirteen analysts that are covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and four have issued a strong buy recommenMarch 13, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Short Interest UpdateSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 7,320,000 shares, an increase of 148.1% from the February 13th total of 2,950,000 shares. Based on an average trading volume of 2,130,000 shares, the days-to-cover ratio is presently 3.4 days. Currently, 12.3% of the company's shares are sold short.March 13, 2025 | marketbeat.comSolid Biosciences (SLDB) Receives a Buy from J.P. MorganMarch 12, 2025 | markets.businessinsider.comSolid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific ConferenceMarch 12, 2025 | globenewswire.comEquities Analysts Offer Predictions for SLDB Q1 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at HC Wainwright lifted their Q1 2025 EPS estimates for shares of Solid Biosciences in a report released on Monday, March 10th. HC Wainwright analyst A. He now expects that the company will post earnings of ($0.43) per share fMarch 12, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Trading Down 4.9% - What's Next?Solid Biosciences (NASDAQ:SLDB) Shares Down 4.9% - Here's WhyMarch 11, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Shares Down 3.1% - Here's What HappenedSolid Biosciences (NASDAQ:SLDB) Trading Down 3.1% - Here's What HappenedMarch 11, 2025 | marketbeat.comSolid Biosciences price target raised to $20 from $16 at H.C. WainwrightMarch 10, 2025 | markets.businessinsider.comSolid Biosciences (SLDB) Gets a Buy from Truist FinancialMarch 10, 2025 | markets.businessinsider.comHC Wainwright Increases Solid Biosciences (NASDAQ:SLDB) Price Target to $20.00HC Wainwright raised their target price on Solid Biosciences from $16.00 to $20.00 and gave the company a "buy" rating in a research note on Monday.March 10, 2025 | marketbeat.comFY2026 Earnings Forecast for SLDB Issued By William BlairSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Investment analysts at William Blair issued their FY2026 earnings estimates for shares of Solid Biosciences in a note issued to investors on Friday, March 7th. William Blair analyst S. Corwin forecasts that the company will earn ($2.76) per shaMarch 10, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Receives "Buy" Rating from Chardan CapitalChardan Capital reiterated a "buy" rating and issued a $16.00 target price on shares of Solid Biosciences in a research note on Friday.March 8, 2025 | marketbeat.comSolid Biosciences Reports Positive Data from Duchenne Gene Therapy Trial and Provides Business UpdateMarch 8, 2025 | nasdaq.comSolid Biosciences (SLDB) Gets a Buy from Chardan CapitalMarch 7, 2025 | markets.businessinsider.comSolid Biosciences (NASDAQ:SLDB) Posts Earnings Results, Misses Expectations By $0.12 EPSSolid Biosciences (NASDAQ:SLDB - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.89) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by ($0.12).March 7, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Releases Earnings Results, Misses Expectations By $0.12 EPSSolid Biosciences (NASDAQ:SLDB - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.89) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.77) by ($0.12).March 7, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Stock Price Down 1.1% - What's Next?Solid Biosciences (NASDAQ:SLDB) Stock Price Down 1.1% - What's Next?March 7, 2025 | marketbeat.comPiper Sandler Remains a Buy on Solid Biosciences (SLDB)March 7, 2025 | markets.businessinsider.comSolid Biosciences Inc.: Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesMarch 7, 2025 | finanznachrichten.deSolid Biosciences files to sell 364,990 shares of common stock for holdersMarch 7, 2025 | markets.businessinsider.comBarclays Remains a Buy on Solid Biosciences (SLDB)March 7, 2025 | markets.businessinsider.comSolid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesMarch 6, 2025 | globenewswire.comSolid Biosciences to Participate at Upcoming Investor ConferencesMarch 5, 2025 | globenewswire.comSolid Biosciences (SLDB) Expected to Announce Quarterly Earnings on WednesdaySolid Biosciences (NASDAQ:SLDB) will be releasing earnings before the market opens on Wednesday, March 12, Financial Modeling Prep reports.March 5, 2025 | marketbeat.comIs Solid Biosciences Inc. (SLDB) Among Stocks With At Least $20 Million In Insider Spending Recently?March 4, 2025 | insidermonkey.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 4, 2025 | globenewswire.comSolid Biosciences' SWOT analysis: gene therapy stock poised for pivotal dataFebruary 28, 2025 | uk.investing.com Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address SLDB Media Mentions By Week SLDB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLDB News Sentiment▼0.240.72▲Average Medical News Sentiment SLDB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLDB Articles This Week▼73▲SLDB Articles Average Week Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Enliven Therapeutics News Today X4 Pharmaceuticals News Today Zymeworks News Today Pharvaris News Today Spyre Therapeutics News Today Mineralys Therapeutics News Today Intellia Therapeutics News Today Nurix Therapeutics News Today Gyre Therapeutics News Today Arcus Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLDB) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLDB Stock Free SLDB Stock Alerts